The U.S. Food and Drug Administration (FDA) has delayed by three months its decision on whether or not to approve Sanofi’s tolebrutinib as a treatment for multiple sclerosis (MS), pushing […]
The post FDA pushes back to December its decision on Sanofi’s tolebrutinib appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com